MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
319.69M
P/E Ratio
N/A
Total Cash
212.61M
Projected Growth
N/A
Total Debt
13.98M
Revenue
38.91M
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash/Share
8.21
Total Debt/Equity
N/A
Revenue/Share
2.24 USD as % of share price
Fundamentals
RNAC
Capitalization
320M
P/E Ratio
N/A
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash
213M
Total Cash/Share
8.21
Total Debt
14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.24%
Revenue
38.9M
ROE
N/A
Book Value
-6.8M
P/B Ratio
588.24
Cash Flow
N/A
Earnings
-4.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
9.43
Current Revenue Per Employee
10184.21
Dividends Per Share - Security
N/A
EBITDA
-75.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.92
Shares Held By Institutions
200M
Shares Outstanding - Current
25.9M
Total Liabilities
442M
Total Volume MTD
N/A
Value
-1
Gain YTD
-31.100
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com